This to me seems like its a done deal somewhere soon, working out how much dosage needed. mm be like, here pharma make this and sell it and make us a bucket load.
To thisend, Biotron has engaged an international contract research organisation to complete chronic toxicology studies of
BIT225 to enable the long-term human dosing required for this next stage of clinical development.
Ann: Presentation of HIV Data to CROI and New Patents, page-7
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
